XenoPort shares dive after new drug application withdrawal(0)
XenoPort of Santa Clara and its partner said Monday they withdrew their new drug application for Solzira, its time-released treatment of moderate-to-severe restless drug syndrome after the Food and Drub Administration asked for modifications to a study.
The news sent shares of XenoPort down Read the rest of this entry »
Subscribe via RSS all feeds